GFAP and early-onset autosomal dominant Alzheimer disease: Baiardi et al.142 found that plasma GFAP, measured using the Simoa SR-X platform, could differentiate Alzheimer’s disease from frontotemporal dementia and supranuclear palsy with respective receiver operating characteristic (ROC) curve AUCs of 0.82 and 0.77, respectively.